Company news
Kuros Biosciences Ltd. (SIX:KURN) news
Kuros Biosciences Ltd. news releases on 6ix. Latest, Aug 13, 2026: Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall…
Press releases & updates
Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability
August 13, 2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
May 7, 2026
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
April 14, 2026
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
March 10, 2026
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
January 13, 2026
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
December 2, 2025
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
October 16, 2025
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
September 30, 2025
Kuros statement on media inquiry concerning former Board member
September 18, 2025
Kuros Biosciences announces changes in the Board of Directors
September 4, 2025
Kuros Biosciences Reports First Half of 2025 Results
August 14, 2025
Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance
August 5, 2025
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
May 13, 2025
Annual General Meeting of Kuros Biosciences approves all resolutions
April 15, 2025
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
April 15, 2025
Kuros Biosciences grows sales to CHF 75.6 million for 2024
March 11, 2025